Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HIV-1 gp160 (315-329)

Known as: P18(IIIB), P18III(B), P18IIIB 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

HIV Envelope Protein gp160Peptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Analysis of the extracellular processing of HIV-1 gp160-derived peptides using monoclonal antibodies specific to H-2Dd molecule complexed with p18-I10 peptide.
The immunodominant peptide of human immunodeficiency virus 1 gp 160 for murine cytotoxic T cells of H-2d haplotype, has been… Expand
2000
2000
Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus‐1 envelope protein‐derived peptide to epitope‐specific cytotoxic T lymphocytes
An immunodominant epitope of human immunodeficiency virus‐1 (HIV‐1) gp160 recognized by Dd class I major histocompatibility… Expand
1999
1999
Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1 envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8+ CTL
SummaryWe constructed recombinant vaccinia viruses (RVV) expressing a 15-residue peptide (P18IIIB; RIQRGPGRAFVTIGK) of gp160… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1998
Highly Cited
1998
Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin‐like growth factor in HIV‐infected patients
Objective:To study the immunologic effects of recombinant human growth hormone (rhGH), recombinant human insulin-like growth… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE